Published in Circulation on June 05, 2001
Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy | NCT00558584
Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J Clin Invest (2004) 1.77
Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail (2009) 1.61
Myocardial gene expression profiles and cardiodepressant autoantibodies predict response of patients with dilated cardiomyopathy to immunoadsorption therapy. Eur Heart J (2012) 1.44
Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol (2008) 1.00
Autoimmunological features in inflammatory cardiomyopathy. Clin Res Cardiol (2007) 0.99
How can we cure a heart "in flame"? A translational view on inflammation in heart failure. Basic Res Cardiol (2013) 0.94
IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study. Ann Rheum Dis (2005) 0.89
Herbal medicines for viral myocarditis. Cochrane Database Syst Rev (2004) 0.86
Inflammation, ECG changes and pericardial effusion: whom to biopsy in suspected myocarditis? Clin Res Cardiol (2006) 0.85
Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system. Heart Fail Rev (2004) 0.85
Variants of Toll-like receptor 4 predict cardiac recovery in patients with dilated cardiomyopathy. J Biol Chem (2012) 0.82
Cytokines as new treatment targets in chronic heart failure. Curr Control Trials Cardiovasc Med (2001) 0.82
Immunoadsorption therapy for patients with dilated cardiomyopathy and heart failure. Curr Cardiol Rev (2008) 0.81
Standard and etiology-directed evidence-based therapies in myocarditis: state of the art and future perspectives. Heart Fail Rev (2013) 0.80
Herbal medicines for viral myocarditis. Cochrane Database Syst Rev (2010) 0.80
Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev (2013) 0.80
B-cell epitope spreading is a critical step for the switch from C-protein-induced myocarditis to dilated cardiomyopathy. Am J Pathol (2007) 0.79
Effect of protein A immunoadsorption on T cell activation in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol (2010) 0.79
A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and design. Can J Cardiol (2007) 0.79
Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies. Neth Heart J (2012) 0.79
Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study. Clin Res Cardiol (2011) 0.78
Effects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy. Clin Res Cardiol (2011) 0.78
Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction. Med Microbiol Immunol (2003) 0.76
Dilated cardiomyopathy update: infectious-immune theory revisited. Heart Fail Rev (2013) 0.76
Sex- and gender-specific research priorities for the emergency management of heart failure and acute arrhythmia: proceedings from the 2014 Academic Emergency Medicine Consensus Conference Cardiovascular Research Workgroup. Acad Emerg Med (2014) 0.75
Plasma exchange for the patients with dilated cardiomyopathy in children is safe and effective in improving both cardiac function and daily activities. J Artif Organs (2017) 0.75
Safety and Efficacy of Immunoadsorption as an Add-On to Medical Treatment in Patients with Severe Idiopathic Pulmonary Arterial Hypertension. Respiration (2017) 0.75
Therapy with immunoglobulin in patients with acute myocarditis and cardiomyopathy: analysis of leukocyte balance. Heart Vessels (2013) 0.75
A molecular model of membrane excitability. J Supramol Struct (1974) 4.60
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation (1993) 4.52
A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A (1997) 3.42
Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation (1991) 2.97
AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. Circulation (2000) 2.57
Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation (2000) 2.54
Acute right-sided heart failure due to hemorrhage into a pericardial cyst. Ann Thorac Surg (1997) 2.24
Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation (1997) 2.16
Revised Cutaneous Lupus Erythematosus Disease Area and Severity Index (RCLASI): a modified outcome instrument for cutaneous lupus erythematosus. Br J Dermatol (2010) 2.12
A child with phenotypic Laron dwarfism and normal somatomedin levels. N Engl J Med (1989) 2.08
Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation (1999) 2.05
Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure. Circ Res (1994) 2.04
Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke (1999) 2.00
Nucleotide sequence analysis of soybean small heat shock protein genes belonging to two different multigene families. J Mol Biol (1988) 1.93
Monitoring depth of anaesthesia in a randomized trial decreases the rate of postoperative delirium but not postoperative cognitive dysfunction. Br J Anaesth (2013) 1.90
HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. Hypertension (2001) 1.84
Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes. J Mol Cell Cardiol (2001) 1.80
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest (2000) 1.76
[The cardiovascular risk factor in obesity]. Dtsch Med Wochenschr (2000) 1.73
Decreased expression of the cardiac LIM domain protein MLP in chronic human heart failure. Circulation (2000) 1.73
Establishment of normal, terminally differentiating mouse erythroid progenitors: molecular characterization by cDNA arrays. FASEB J (2001) 1.70
Erectile dysfunction correlates with left ventricular function and precedes cardiovascular events in cardiovascular high-risk patients. Int J Clin Pract (2007) 1.69
Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation (1998) 1.69
Coronary atherogenic risk factors in women. Eur Heart J (2002) 1.68
Risk factors for inadequate emergence after anesthesia: emergence delirium and hypoactive emergence. Minerva Anestesiol (2010) 1.67
Association of airflow limitation with trauma exposure and post-traumatic stress disorder. Eur Respir J (2010) 1.67
Myocardial fibrosis in transforming growth factor-beta(1) (TGF-beta(1)) transgenic mice is associated with inhibition of interstitial collagenase. Eur J Clin Invest (2002) 1.67
Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men. Circulation (1999) 1.67
Expression of beta-arrestins and beta-adrenergic receptor kinases in the failing human heart. Circ Res (1994) 1.66
Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation (1997) 1.64
Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the beta 1-adrenoceptor with positive chronotropic effect. Circulation (1994) 1.63
Adenosine as inhibitor of myocardial effects of catecholamines. Pflugers Arch (1977) 1.58
Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol (2000) 1.58
Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol (2001) 1.55
Clinical profiles and outcomes in patients with chronic heart failure and chronic obstructive pulmonary disease: an efficacy and safety analysis of SHIFT study. Int J Cardiol (2013) 1.55
Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods. J Thromb Haemost (2003) 1.54
Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. Mol Pharmacol (2001) 1.51
Role of Kozak sequence polymorphism of platelet glycoprotein Ibalpha as a risk factor for coronary artery disease and catheter interventions. J Am Coll Cardiol (2001) 1.51
Relationship between haemodynamics and morphology in pulmonary hypertension. A quantitative intravascular ultrasound study. Eur Heart J (1997) 1.49
Expression of atrial myosin light chains but not alpha-myosin heavy chains is correlated in vivo with increased ventricular function in patients with hypertrophic obstructive cardiomyopathy. J Mol Med (Berl) (1999) 1.48
Phase-related changes in right ventricular cardiac output under volume-controlled mechanical ventilation with positive end-expiratory pressure. Crit Care Med (1999) 1.47
Correction and withdrawal of conclusion--a child with phenotypic Laron dwarfism and normal somatomedin levels. N Engl J Med (1990) 1.46
Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene. J Am Coll Cardiol (2000) 1.45
Investigation of the male pattern baldness major genetic susceptibility loci AR/EDA2R and 20p11 in female pattern hair loss. Br J Dermatol (2012) 1.44
Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation (2001) 1.43
Cellular adhesion molecules on vascular smooth muscle cells. Cardiovasc Res (1999) 1.43
[New findings on the action of HMG-CoA-reductase inhibitors]. Dtsch Med Wochenschr (1997) 1.42
Defining the optimum upper heart rate limit during exercise: a study in pacemaker patients with heart failure. Eur Heart J (2002) 1.41
Xamoterol and the failing heart. Lancet (1989) 1.41
Pregnancy performance of patients under fifteen years of age. Obstet Gynecol (1975) 1.41
Suppression of endothelial nitric oxide production after withdrawal of statin treatment is mediated by negative feedback regulation of rho GTPase gene transcription. Circulation (2000) 1.41
[Management of sleep-related abnormal breathing by cardiologists and hospital departments of cardiology]. Dtsch Med Wochenschr (2010) 1.40
Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke (2000) 1.40
Late results of mitral valve reconstruction in the elderly. Ann Thorac Surg (2000) 1.39
[Preoperative cardiovascular risk evaluation--diagnosis]. Dtsch Med Wochenschr (2004) 1.39
[Atrial fibrillation]. Dtsch Med Wochenschr (2006) 1.39
[Dissection of the ramus interventricularis anterior in blunt chest trauma]. Dtsch Med Wochenschr (1999) 1.39
[Clinical features and current treatment of hypertensive crisis]. Dtsch Med Wochenschr (2003) 1.39
Effects of different steroid treatment on reperfusion-associated production of reactive oxygen species and arrhythmias during coronary surgery. Acta Anaesthesiol Scand (2003) 1.39
[Alcohol and myocardial infarct. Epidemiological and experimental studies on the effect of alcohol on vascular relaxation and coronary sclerosis]. Dtsch Med Wochenschr (1998) 1.39
Pulmonary adrenomedullin counteracts deterioration of coronary flow and myocardial performance evoked by pulmonary endothelins in experimental acute respiratory distress syndrome. Crit Care Med (2001) 1.39
[Pyoderma gangraenosum--a rare complication after breast reduction]. Handchir Mikrochir Plast Chir (1992) 1.38
[Statins as new therapeutic possibility in osteoporosis?]. Dtsch Med Wochenschr (2001) 1.38
The pregnancy hormone relaxin is a player in human heart failure. FASEB J (2001) 1.32
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J Immunol (2001) 1.32
The failing human heart is unable to use the Frank-Starling mechanism. Circ Res (1994) 1.31
A specific growth hormone-binding protein in human plasma: initial characterization. J Clin Endocrinol Metab (1986) 1.31
Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab (1996) 1.29
Thermo-induced transcripts of a soybean heat shock gene after transfer into sunflower using a Ti plasmid vector. EMBO J (1985) 1.28
Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A. Oncogene (2007) 1.28
International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol (2001) 1.28
Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens (2000) 1.26
Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci U S A (1999) 1.25
Systemic anaphylaxis--separation of cardiac reactions from respiratory and peripheral vascular events. Res Exp Med (Berl) (1990) 1.25
[Guidelines for therapy of chronic heart failure]. Z Kardiol (2005) 1.24
Guidelines for the management of vitiligo: the European Dermatology Forum consensus. Br J Dermatol (2012) 1.24
Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. J Clin Endocrinol Metab (1999) 1.23
Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med (1995) 1.23
Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells. Circulation (1997) 1.23
Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR. Oncogene (2006) 1.22
Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation (2000) 1.22
Insulin receptors in acute infection: a study of factors conferring insulin resistance. J Clin Endocrinol Metab (1984) 1.21
Secular trends in neonatal macrosomia in Berlin: influences of potential determinants. Paediatr Perinat Epidemiol (2003) 1.21
Functional autoimmune epitope on alpha 1-adrenergic receptors in patients with malignant hypertension. Lancet (1994) 1.21
Catalytic specificity of phosphotyrosine kinases Blk, Lyn, c-Src and Syk as assessed by phage display. J Mol Biol (1996) 1.20
E-selectin polymorphism and atherosclerosis: an association study. Hum Mol Genet (1994) 1.19